DOCS250117P52500
- 0.65
- +0.14+27.45%
Doximity Newsroom
KeyBanc Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $65
KeyBanc Cuts Price Target on Doximity to $65 From $70, Keeps Overweight Rating
Doximity Is Maintained at Neutral by B of A Securities
Doximity Analyst Ratings
BofA Securities Adjusts Price Target on Doximity to $57 From $54
BofA Securities Maintains Doximity(DOCS.US) With Hold Rating, Raises Target Price to $57
Stephens Initiates Doximity(DOCS.US) With Hold Rating, Announces Target Price $55
Doximity Analyst Ratings
Stephens Initiates Coverage on Doximity With Equal Weight Rating, $55 Price Target
Doximity Hold Rating: Balancing Strong Market Position With Political and Competitive Uncertainties
Doximity Analyst Ratings
Mizuho Initiates Coverage On Doximity With Neutral Rating, Announces Price Target of $55
Jefferies Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $64
Jefferies Maintains Doximity(DOCS.US) With Buy Rating, Raises Target Price to $64
Doximity Is Maintained at Neutral by JP Morgan
Doximity Analyst Ratings
Doximity Initiated With a Neutral at Goldman Sachs
Goldman Sachs Initiates Doximity(DOCS.US) With Hold Rating, Announces Target Price $58
Balanced Risk/Reward Scenario Leads to Neutral Stance on Doximity
Baird Maintains Doximity(DOCS.US) With Buy Rating, Raises Target Price to $61